Genomic Valley Biotech Ltd — Important, 14-04-2026: Company Update

Genomic Valley Biotech Limited has confirmed its compliance regarding the dematerialization of shares for the quarter ending March 2026. The company's Registrar and Share Transfer Agent verified that all securities received for dematerialization were duly processed: confirmed to depositories, listed on exchanges, and physical certificates cancelled. Shareholder records were updated by substituting depositories as registered owners within the mandated period. This ensures proper and timely management of shareholder holdings and adherence to market regulations.